This phenotype was reversible when the APOE4 mutation was converted to APOE3. A simultaneously published study also formed brain organoids from hiPSCs derived from familial and sporadic AD patients and used a dual chamber microfluidics device to study their cellular interactions (Park et al., 2018). The gene discussed is APOE; the disease is Alzheimer disease.